+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 52 Pages
  • October 2022
  • GlobalData
  • ID: 5125692
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company's business strategy.
  • SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over the counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Mitsubishi Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Mitsubishi Tanabe is headquartered in Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

  • Jul 13, 2022: Mitsubishi Tanabe Pharma : Humanitarian donation to Ukraine
  • Feb 03, 2022: Mitsubishi Tanabe Pharma Financial Information for 3Q of FY2021
  • Aug 04, 2021: Mitsubishi Tanabe Pharma: Consolidated financial results for the first quarter of the Fiscal Year Ending March 31, 2022
  • May 25, 2021: Establishment of AI Technologies for drug screening to accelerate data-driven drug discovery
  • Mar 31, 2021: The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishmaniasis drug discovery

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Mitsubishi Tanabe Pharma Corp - Key Facts
  • Mitsubishi Tanabe Pharma Corp - Key Employees
  • Mitsubishi Tanabe Pharma Corp - Key Employee Biographies
  • Mitsubishi Tanabe Pharma Corp - Major Products and Services
  • Mitsubishi Tanabe Pharma Corp - History
  • Mitsubishi Tanabe Pharma Corp - Company Statement
  • Mitsubishi Tanabe Pharma Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Mitsubishi Tanabe Pharma Corp - Business Description
  • Product Category: Domestic Ethical Drugs
  • Performance
  • Product Category: Overseas Ethical Drugs
  • Performance
  • Product Category: Royalty Revenue, etc.
  • Performance
  • Geographical Segment: Domestic
  • Performance
  • Geographical Segment: Overseas
  • Performance
  • R&D Overview
  • Mitsubishi Tanabe Pharma Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Mitsubishi Tanabe Pharma Corp - Strengths
  • Mitsubishi Tanabe Pharma Corp - Weaknesses
  • Mitsubishi Tanabe Pharma Corp - Opportunities
  • Mitsubishi Tanabe Pharma Corp - Threats
  • Mitsubishi Tanabe Pharma Corp - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jul 13, 2022: Mitsubishi Tanabe Pharma : Humanitarian donation to Ukraine
  • Feb 03, 2022: Mitsubishi Tanabe Pharma Financial Information for 3Q of FY2021
  • Aug 04, 2021: Mitsubishi Tanabe Pharma: Consolidated financial results for the first quarter of the Fiscal Year Ending March 31, 2022
  • May 25, 2021: Establishment of AI Technologies for drug screening to accelerate data-driven drug discovery
  • Mar 31, 2021: The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishmaniasis drug discovery
  • Mar 17, 2021: Mitsubishi Tanabe Pharma America presents data on impact of ALS Symptoms on patients' ability to independently conduct daily activities
  • Mar 03, 2021: Mitsubishi Tanabe Pharma: Establish NeuroDiscovery Lab in the Boston area to strengthen the discovery of drug targets for the Central Nervous System Disorders
  • Mar 03, 2021: Mitsubishi Tanabe Pharma: Formulation of MISSION, VISION 30 and Medium-Term Management Plan 21-25 -Creating hope for all facing illness
  • Mar 03, 2021: Mitsubishi Tanabe Pharma America announces establishment of NeuroDiscovery Lab Research Base in Cambridge, Mass
  • Feb 03, 2021: Mitsubishi Tanabe Pharma: Financial results for the 3rd Quarter of FY2020 ending March 31, 2021 and Forecasts for FY2020
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Mitsubishi Tanabe Pharma Corp, Key Facts
  • Mitsubishi Tanabe Pharma Corp, Key Employees
  • Mitsubishi Tanabe Pharma Corp, Key Employee Biographies
  • Mitsubishi Tanabe Pharma Corp, Major Products and Services
  • Mitsubishi Tanabe Pharma Corp, History
  • Mitsubishi Tanabe Pharma Corp, Other Locations
  • Mitsubishi Tanabe Pharma Corp, Subsidiaries
  • Mitsubishi Tanabe Pharma Corp, Joint Venture
  • Mitsubishi Tanabe Pharma Corp, Key Competitors
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
List of Figures
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Tsumura & Co
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Chugai Pharmaceutical Co Ltd
  • Tsumura & Co
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Chugai Pharmaceutical Co Ltd